Head and Neck cancer Head and Neck cancer
Conditions
Interventions
Treatment with dietary glucosylceramide
Sponsors
Fujiwara Kazunori
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Origin of the cancer: maxillary, oral cavity, pharynx, larynx, cervical esophagus Recieve chemoradiation against head and neck cancer Over 20 years old Enable to take a medicine orally Patient with bone marrow, and/or hepatic, and/or renal insufficiency within 14 days before starting of a trial Sign a consent form on one's own
Exclusion criteria
Exclusion criteria: Konjac allergy Prominent symptom at the site of a skin test Patient who had chronic skin disorder like collagen diseases and take medication regularly Remain under other scrutiny, or within 3 months after finishing other clinical trial Asthma patients Take antihistamine medicine At risk of becoming pregnant and breast-feeding woman
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| degree of the adverse event for the radiation field | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain, degree, onset, and course of the adverse skin event Amount of the sphingolipids at the skin Evaluation of the skin function about transpiration rate, amount of moisture, and range of erythema and macule Adverse event, side effect | — |
Contacts
Public ContactKazunori Fujiwara
Tottori University Hospital
Outcome results
None listed